Kazia Therapeutics Limited (Nasdaq: KZIA), an oncology-focused drug development company, today announced that a patient with stage IV triple-negative breast cancer (TNBC) treated under an FDA-authorized single-patient expanded access protocol combining paxalisib with pembrolizumab (Keytruda®) and standard chemotherapy has achieved an initial immune-complete response (iCR) per iRECIST criteria. This outcome suggests a profound radiologic response […]

On November 5, 2025, a hearing panel of the Canadian Investment Regulatory Organization (CIRO) held a hearing pursuant to the Mutual Fund Dealer Rules and accepted a settlement agreement, with sanctions, between Enforcement Staff and Thomas Leonard Keough. ThomasKeoughadmitted to failing to identify, report to the Dealer Member, or address in the best interests of

(NASDAQ:CHMG), ELMIRA, N.Y., Nov. 18, 2025 (GLOBE NEWSWIRE) — Chemung Financial Corporation (Nasdaq: CHMG) announced today that its Board of Directors has approved a quarterly cash dividend of $0.34 per share, payable on January 2, 2026, to common stock shareholders of record as of the close of business on December 19, 2025. Chemung Financial Corporation

(NYSE:LZB), Fiscal 2026 Second Quarter Highlights: Delivered sales of $522 million, up slightly from prior year period Retail segment written sales increased 4% Same-store sales trends improved sequentially Opened five new company-owned stores (and closed three); opened 15 new stores in the last 12 months (and closed five) Wholesale segment delivered sales increased 2% Consolidated

(NYSE:SPNT), HAMILTON, Bermuda, Nov. 18, 2025 (GLOBE NEWSWIRE) — SiriusPoint Ltd. (“SiriusPoint” or the “Company”) (NYSE: SPNT), a global specialty insurer and reinsurer, has today announced the appointment of Maria Tarhanidis as Chief Investment Officer, effective December 2, 2025. Based in New York, Ms. Tarhanidis will join the senior leadership team and will report to

(NYSE:TGNA), TYSONS, Va., Nov. 18, 2025 (GLOBE NEWSWIRE) — TEGNA Inc.'s (NYSE: TGNA) Board of Directors declared a regular quarterly dividend of 12.5 cents per share, payable on January 2, 2026, to shareholders of record as of the close of business on December 5, 2025. About TEGNA TEGNA Inc. (NYSE: TGNA) helps people thrive in

(NASDAQ:IPAR), NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) — Interparfums, Inc. (NASDAQ GS: IPAR) (“Interparfums” or the “Company”) today announced initial guidance for its fiscal year ending December 31, 2026. Guidance 2026E 2025E % Change Net Sales $1.48B $1.47B +1% Diluted EPS $4.85 $5.12 (5%) Management CommentaryJean Madar, Chairman & Chief Executive Officer of Interparfums

(TSX-V:NET-UN),(TSX-V:NET-UN.V), MONTRÉAL, Nov. 18, 2025 (GLOBE NEWSWIRE) — Canadian Net Real Estate Investment Trust (“Canadian Net” or the “REIT”) (TSX-V: NET.UN) today reported its results for the quarter ended September 30th, 2025 (“Q3 2025”) and distributions for January, February and March 2026 (“Q1 2026”). “We're pleased with our continued momentum through the third quarter, marked

(TSX:PRN),(NASDAQ:PROF), TORONTO, Nov. 18, 2025 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue, announced today that The Hong Center Scottsdale, led by Dr. Y. Mark Hong of Integrative Urology in Phoenix, Arizona,

(NASDAQ:LESL), PHOENIX, Nov. 18, 2025 (GLOBE NEWSWIRE) — Leslie's, Inc. (NASDAQ: LESL), the largest and most trusted direct-to-customer brand in the U.S. pool and spa care industry serving residential customers and pool professionals nationwide, today announced it will release its fourth quarter and full year fiscal 2025 financial results after market close on Tuesday, December